Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

ClinicalTrials.gov ID: NCT01962987

Public ClinicalTrials.gov record NCT01962987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 3:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Diclofenac Sodium Gel 3% (Actavis) to Solaraze ® (Diclofenac Sodium) Gel 3% (Fougera Pharms) in the Treatment of Actinic Keratosis

Study identification

NCT ID
NCT01962987
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actavis Inc.
Industry
Enrollment
476 participants

Conditions and interventions

Interventions

  • Diclofenac sodium Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2013
Primary completion
Aug 31, 2013
Completion
Aug 31, 2013
Last update posted
Jul 19, 2020

2013

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Investigator Site 23 Fremont California
Investigator Site 9 Long Beach California
Investigator Site 12 Newport Beach California
Investigator Site 2 San Diego California
Investigator Site 24 San Ramon California
Investigator Site 14 Denver Colorado
Investigator Site 17 Denver Colorado
Investigator Site 21 Brandon Florida
Investigator Site 25 Dunedin Florida
Investigator Site 20 Fort Myers Florida
Investigator Site 15 Jacksonville Florida
Investigator Site 16 Miami Florida
Investigator Site 6 Ormond Beach Florida
Investigator Site 19 Winter Park Florida
Investigator Site 22 Atlanta Georgia
Investigator Site 11 Boise Idaho
Investigator Site 8 Arlington Heights Illinois
Investigator Site 28 Plainfield Indiana
Investigator Site 31 Louisville Kentucky
Investigator Site 27 Fridley Minnesota
Investigator Site 13 Bozeman Montana
Investigator Site 26 New Bern North Carolina
Investigator Site 3 Raleigh North Carolina
Investigator Site 18 Wilmington North Carolina
Investigator Site 30 Cincinnati Ohio
Investigator Site 1 Hazleton Pennsylvania
Investigator Site 5 Clinton South Carolina
Investigator Site 4 Johnson City Tennessee
Investigator Site 10 Nashville Tennessee
Investigator Site 7 West Jordan Utah
Investigator Site 29 Midlothian Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01962987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01962987 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →